Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kim, Jung Lye ^a   Kim, Yun Ho ^a   Kang, Min Kyung ^a   Gong, Ju Hyun ^a   Han, Seoung Jun ^b   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

^b Seorim Bio   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIESTROGEN; CATHEPSIN K; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; OSTEOPROTEGERIN; SILIBININ; SILYBUM MARIANUM EXTRACT; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ESTRADIOL; ISOENZYME; PLANT EXTRACT; SILYMARIN; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOSTEOCLASTIC ACTIVITY; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ESTROGEN DEFICIENCY; FEMALE; FEMUR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSAL OSTEOPENIA; SILYBUM MARIANUM; TISSUE CULTURE; TREATMENT DURATION; ANIMAL; BLOOD; BONE DEVELOPMENT; C57BL MOUSE; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYTOTHERAPY; SOYBEAN; UTERUS; DRUG EFFECT;

MUS; SILYBUM MARIANUM;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; CATHEPSIN K; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; ESTROGENS; FEMALE; FEMUR; ISOENZYMES; MICE; MICE, INBRED C57BL; MILK THISTLE; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; SILYMARIN; SOYBEANS; UTERUS;

EID: 84879365271     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/919374     Document Type: Article

References (29)

1. Kanis J. A., Osteoporosis III: diagnosis of osteoporosis and assessment of fracture risk. The Lancet 2002 359 9321 1929 1936 2-s2.0-0036606093 10.1016/S0140-6736(02)08761-5 (Pubitemid 34615775)
2. Fraser L. A., Vogt K. N., Adachi J. D., Thabane L., Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis. Therapeutics and Clinical Risk Management 2011 7 157 166
3. Wensel T. M., Iranikhah M. M., Wilborn T. W., Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. Pharmacotherapy 2011 31 5 510 523 2-s2.0-79955596910 10.1592/phco.31.5.510
4. Beard M. K., Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference. Current Medical Research and Opinion 2012 28 1 141 147 10.1185/03007995.2011.643296
5. Silverman S., Christiansen C., Individualizing osteoporosis therapy. Osteoporos International 2012 23 3 797 809 10.1007/s00198-011-1775-y
6. Åkesson K., New approaches to pharmacological treatment of osteoporosis. Bulletin of the World Health Organization 2003 81 9 657 664 2-s2.0-0141989663 (Pubitemid 37254687)
7. Putnam S. E., Scutt A. M., Bicknell K., Priestley C. M., Williamson E. M., Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytotherapy Research 2007 21 2 99 112 2-s2.0-33846996015 10.1002/ptr.2030
8. Banu J., Varela E., Fernandes G., Alternative therapies for the prevention and treatment of osteoporosis. Nutrition Reviews 2012 70 1 22 40
9. Sunita P., Pattanayak S. P., Phytoestrogens in postmenopausal indications: a theoretical perspective. Pharmacognosy Reviews 2011 5 9 41 47 2-s2.0-79955097213 10.4103/0973-7847.79098
10. Al-Anazi A. F., Qureshi V. F., Javaid K., Qureshi S., Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: an overview. Journal of Natural Science and Biological Medicine 2011 2 2 154 163 10.4103/0976-9668.92322
11. Turner J. V., Agatonovic-Kustrin S., Glass B. D., Molecular aspects of phytoestrogen selective binding at estrogen receptors. Journal of Pharmaceutical Sciences 2007 96 8 1879 1885 2-s2.0-34548039683 10.1002/jps.20987 (Pubitemid 47280089)
12. +CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One 2011 6 6 2-s2.0-79959435355 10.1371/journal.pone.0021216 e21216
13. Tseng P. C., Hou S. M., Chen R. J., Peng H. W., Hsieh C. F., Kuo M. L., Yen M. L., Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. Journal of Pharmaceutical Sciences 2011 26 10 2552 2563
14. Kim J. L., Park S. H., Jeong D., Nam J. S., Kang Y. H., Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice. Experimental Biological Medicine 2012 237 4 417 428 10.1258/ebm.2011.011376
15. Lu P., Mamiya T., Lu L. L., Mouri A., Zou L. B., Nagai T., Hiramatsu M., Ikejima T., Nabeshima T., Silibinin prevents amyloid b peptide-induced memory impairment and oxidative stress in mice. British Journal of Pharmacology 2009 157 7 1270 1277 2-s2.0-70349337734 10.1111/j.1476-5381.2009.00295.x
16. Sangeetha N., Aranganathan S., Panneerselvam J., Shanthi P., Rama G., Nalini N., Oral supplementation of silibinin prevents colon carcinogenesis in a long term preclinical model. European Journal of Pharmacology 2010 643 1 93 100 2-s2.0-77955052581 10.1016/j.ejphar.2010.05.060
17. Kim J. L., Kang S. W., Kang M. K., Gong J. H., Lee E. S., Han S. J., Kang Y. H., Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts. Journal of Cellular Biochemistry 2012 113 1 247 259 10.1002/jcb.23351
18. Ryou S. H., Kang M. S., Kim K. I., Kang Y. H., Kang J. S., Effects of green tea or Sasa quelpaertensis bamboo leaves on plasma and liver lipids, erythrocyte Na efflux, and platelet aggregation in ovariectomized rats. Nutrition Research Practice 2012 6 2 356 361
19. Akcakaya H., Aroymak A., Gokce S., A quantitative colorimetric method of measuring alkaline phosphatase activity in eukaryotic cell membranes. Cell Biology International 2007 31 2 186 190 2-s2.0-33846633660 10.1016/j.cellbi. 2006.11.014 (Pubitemid 46187107)
20. Liu H., Yuan Q., Li C. F., Huang T. X., Isolation and purification of silychristin, silydianin and taxifolin in the co-products of the silybin refined process from the silymarin by high-speed counter-current chromatography. Process Biochemistry 2010 45 5 799 804 2-s2.0-77950299488 10.1016/j.procbio. 2010.01.004
21. Lee J. I., Hsu B. H., Wu D., Barrett J. S., Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry. Journal of Chromatography A 2006 1116 1-2 57 68 2-s2.0-33745571251 10.1016/j.chroma.2006.03.053 (Pubitemid 44287926)
22. Lee D. Y. W., Liu Y., Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, isolated from Silybum marianum (milk thistle). Journal of Natural Products 2003 66 9 1171 1174 2-s2.0-0141566436 (Pubitemid 37204213)
23. Boonen S., Rosenberg E., Claessens F., Vanderschueren D., Papapoulos S., Inhibition of cathepsin K for treatment of osteoporosis. Current Osteoporosis Reports 2012 10 1 73 79 10.1007/s11914-011-0085-9
24. North American Menopause Society, The 2012 hormone therapy position statement of: the North American Menopause Society. Menopause 2012 19 3 257 271 10.1097/gme.0b013e31824b970a
25. Sutton E. E., Riche D. M., Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis. Annals of Pharmacotherapy 2012 46 7-8 1000 1009 10.1345/aph.1Q543
26. Wu J., Wang X., Chiba H., Higuchi M., Nakatani T., Ezaki O., Cui H., Yamada K., Ishimi Y., Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism: Clinical and Experimental 2004 53 7 942 948 2-s2.0-3042523543 10.1016/j.metabol.2004.01.019 (Pubitemid 38829472)
27. Sacco S. M., Jiang J. M. Y., Reza-López S., Ma D. W. L., Thompson L. U., Ward W. E., Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause 2009 16 3 545 554 2-s2.0-67649884790 10.1097/gme.0b013e31818fc00a
28. Schümann J., Prockl J., Kiemer A. K., Vollmar A. M., Bang R., Tiegs G., Silibinin protects mice from T cell-dependent liver injury. Journal of Hepatology 2003 39 3 333 340 2-s2.0-0041828254 10.1016/S0168-8278(03)00239-3 (Pubitemid 37070249)
29. Boyle W. J., Simonet W. S., Lacey D. L., Osteoclast differentiation and activation. Nature 2003 423 6937 337 342 2-s2.0-0037673945 10.1038/nature01658 (Pubitemid 40852708)